Immuno-oncology
Get a quote--Applications of OVA Stable Cell Lines in Immuno-Oncology
Immuno-oncology, also known as cancer immunotherapy. Researchers and clinicians aim to enhance and optimize the body's natural ability to recognize and eliminate cancer cells by manipulating or reinforcing the immune system. The use of OVA (ovalbumin) stable cell lines in immuno-oncology research offers a valuable tool for studying and understanding immune responses in the context of cancer. OVA provides researchers with a controlled system to investigate various aspects of the immune system's interaction with cancer cells.
Why Vitro Biotech’s OVA stable cell lines?
· Stable OVA (ovalbumin) expression.
· Common cell lines from human, mouse, and rat.
· Monclones and stable cell pools available.
· Western Blot validated, STR profiled, mycoplasma free
OVA stable cell lines play a crucial role in advancing our understanding of immune responses in immuno-oncology. The below applications contribute to the development and optimization of novel immunotherapies, ultimately aiming to improve cancer treatment outcomes.
- Model Antigen for Immunogenicity Study
- Antigen Presentation and Dendritic Cell Activation
- T Cell Activation and Proliferation
- Immunotherapy Development and Evaluation
- Study of Immune Checkpoint Pathways
- Tumor Microenvironment Interactions
- In Vivo Models for Immunology Study